Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.93 USD | +4.94% | +3.21% | +71.61% |
05-09 | Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Baird Starts Spyre Therapeutics With Outperform Rating, $50 Price Target | MT |